Segui
maria trojano
maria trojano
Dipartimento di Scienze Mediche di Base, Neuroscienze ed Organi di Senso, Università degli Studi
Email verificata su uniba.it
Titolo
Citata da
Citata da
Anno
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
66802018
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity
R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ...
Neurology 64 (7), 1144-1151, 2005
10622005
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.
M Andersson, J Alvarez-Cermeno, G Bernardi, I Cogato, P Fredman, ...
Journal of Neurology, Neurosurgery & Psychiatry 57 (8), 897-902, 1994
9641994
The genomic history of southeastern Europe
I Mathieson, S Alpaslan-Roodenberg, C Posth, A Szécsényi-Nagy, ...
Nature 555 (7695), 197-203, 2018
7282018
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review
RA Marrie, S Reingold, J Cohen, O Stuve, M Trojano, PS Sorensen, ...
Multiple Sclerosis Journal 21 (3), 305-317, 2015
5772015
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
5532019
Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis
MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ...
Annals of neurology 89 (4), 780-789, 2021
4792021
Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis
JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ...
Jama 321 (2), 175-187, 2019
4652019
Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial
RC Hermida, JJ Crespo, M Domínguez-Sardiña, A Otero, A Moya, ...
European heart journal 41 (48), 4565-4576, 2020
4312020
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview
RA Marrie, J Cohen, O Stuve, M Trojano, PS Sørensen, S Reingold, ...
Multiple Sclerosis Journal 21 (3), 263-281, 2015
4282015
The Rao’s Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population
MP Amato, E Portaccio, B Goretti, V Zipoli, L Ricchiuti, MF De Caro, F Patti, ...
Multiple Sclerosis Journal 12 (6), 787-793, 2006
4122006
Defining secondary progressive multiple sclerosis
J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ...
Brain 139 (9), 2395-2405, 2016
3982016
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome
E Millefiorini, C Gasperini, C Pozzilli, F D’andrea, S Bastianello, ...
Journal of neurology 244, 153-159, 1997
3811997
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study
C Solaro, G Brichetto, MP Amato, E Cocco, B Colombo, G D’aleo, ...
Neurology 63 (5), 919-921, 2004
3792004
Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study
J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ...
Multiple Sclerosis Journal 21 (8), 1013-1024, 2015
3732015
Clinical characteristics, course and prognosis of relapsing Devic’s Neuromyelitis Optica
A Ghezzi, R Bergamaschi, V Martinelli, M Trojano, MR Tola, E Merelli, ...
Journal of neurology 251, 47-52, 2004
3702004
New natural history of interferon‐β–treated relapsing multiple sclerosis
M Trojano, F Pellegrini, A Fuiani, D Paolicelli, V Zipoli, GB Zimatore, ...
Annals of neurology 61 (4), 300-306, 2007
3592007
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open …
R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ...
The Lancet Neurology 17 (5), 405-415, 2018
3332018
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes
L Ruano, E Portaccio, B Goretti, C Niccolai, M Severo, F Patti, S Cilia, ...
Multiple Sclerosis Journal 23 (9), 1258-1267, 2017
3272017
Cognitive and psychosocial features of childhood and juvenile MS
MP Amato, B Goretti, A Ghezzi, S Lori, V Zipoli, E Portaccio, L Moiola, ...
Neurology 70 (20), 1891-1897, 2008
3232008
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20